

https://polpharma.pl/en/polpharma-is-a-leader-among-polish-companies-in-terms-of-the-number-of-european-patent-applications/
https://www.api.polpharma.com/news/cryogenic-infrastructure-at-polpharma-api-facility/
https://www.api.polpharma.com/news/liophilization-what-does-a-strawberry-have-in-common-with-polpharma-api/
https://www.api.polpharma.com/news/polpharmas-strategic-investment-in-hpapi-facility-the-first-of-this-kind-in-poland/
https://www.api.polpharma.com/news/safe-approach-in-delivering-nitrosamine-free-api-products/
https://www.farmaprojects.com/farmaprojects-becomes-part-of-the-polpharma-group/
https://www.contractpharma.com/contents/view_breaking-news/2022-08-03/fda-approves-first-biosimilar-to-lucentis/?widget=listSection
https://www.api.polpharma.com/articles/polpharma-partners-with-pikralida-biopharmaceutical-start-up
https://pikralida.eu/en/polpharma-the-contractor-for-the-key-stage-of-the-epifix-project/
https://www.api.polpharma.com/news/polpharma-partners-with-pikralida-biopharmaceutical-start-up/